RxDoctor Payments Data

Jacob Silverstone

Foot & Ankle Surgery · North Miami, FLNPI 1952555948

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 3 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Amgen accounts for 77.1% of it on its own, with 2 other manufacturers making up the rest. Reporting peaked in 2022 at $124 and has fallen 80.2% since, to $25 in 2023. That places this record below the midpoint for foot & ankle surgery clinicians in FL, where the typical reported total is $3,061.

$161in general payments, 2019–2025

Across 3 payments — averaging $53.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$124
  • Innovation Technologies Inc$25
  • Zimmer Biomet$12
$59,620in research payments, 2019–2025

Across 10 payments — averaging $5961.98 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Ipsen Innovation$60K

What the payments were for

  • Food & beverage$161100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Amgen1$124
Innovation Technologies Inc1$25
Zimmer Biomet1$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$161 in reported general payments places this provider in the 5th percentile of 850 foot & ankle surgery providers in Florida.

See all foot & ankle surgery providers in Florida

Medicare billing

Part B allowed, 2024
$386,885
Medicare patients
41
Services billed
410

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other foot & ankle surgery in North Miami

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →